Defective platelet aggregation in myelodysplastic syndromes

Area of Science:

• Hematology
• Oncology
• Platelet Biology

Background:

• Hemorrhagic tendency in myelodysplastic syndrome (MDS) is primarily linked to low platelet counts.
• Platelet function in MDS patients remains underexplored despite its potential clinical significance.

Purpose of the Study:

• To comprehensively evaluate platelet function in individuals diagnosed with primary MDS.
• To investigate the impact of various agonists on platelet aggregation in MDS.

Main Methods:

• Platelet aggregation was assessed using aggregometry in 26 MDS patients and 15 healthy controls.
• Platelet responses were measured against ristocetin, collagen, adenosine diphosphate (ADP), and adrenaline.

Main Results:

• A significant majority of MDS patients (80.7%) displayed defective platelet aggregation.
• The most pronounced defects were observed with adrenaline (45.9%) and ADP (58.7%) stimulation.
• Refractory anemia with excess blasts in transformation (RAEB-t) subtype showed the most severe platelet dysfunction.

Conclusions:

• Myelodysplastic syndrome patients frequently exhibit impaired platelet aggregation to multiple stimuli.
• Platelet aggregation defects in MDS correlate with poorer disease prognosis.
• Functional platelet defects in MDS do not directly correlate with observed hemorrhagic tendencies.